Dr. David J. Vanderweele, MD

  • Chicago, IL
  • Medical oncologist
NPI1689846834PAC ID4688817588
Medicare services, 2024
47,558
Medicare patients, 2024
537
Part D claims, 2024
947
Publications
11
MIPS score, 2024
95
Practice address
675 N St Clair St, Chicago, IL 60611
Practice phone
Call (312) 695-0646
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Northwestern Medical Group

Chicago, Illinois

See all 9 affiliations

Find Dr. Vanderweele's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David J. Vanderweele is a medical oncologist in Chicago, Illinois

Dr. Vanderweele practices at Northwestern Medical Group in Chicago, Illinois.

Dr. Vanderweele's NPI, 1689846834, was assigned on March 27, 2008. Dr. Vanderweele graduated from University of Chicago, Pritzker School of Medicine in 2007. Dr. Vanderweele holds Illinois license 036123890.

NPI and contact details
Medicare PAC ID
4688817588
NPI enumeration date
March 27, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(312) 695-0646
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. David J. Vanderweele practices at Northwestern Medical Group in Chicago, Illinois

Dr. Vanderweele's primary practice is Northwestern Medical Group, at 675 N St Clair St, Chicago, IL 60611 in Cook County. The practice phone is (312) 695-0646.

  • Northwestern Medical Group
    675 N St Clair St, Chicago, IL 60611 · Cook CountyPhone(312) 695-0646

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. David J. Vanderweele is affiliated with 8 sites of care and 1 medical group

Dr. Vanderweele's primary practice is Northwestern Medical Group in Chicago, Illinois. Dr. Vanderweele is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Vanderweele to 4 more hospitals, 1 group practice or clinic and 1 hospice, each named with a free account.

See all 9 affiliations for Dr. Vanderweele

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. David J. Vanderweele's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vanderweele practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Northwestern Medical GroupAvailable with a free account
+7 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Vanderweele practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David J. Vanderweele is one of 153 medical oncologists in Illinois

Medical oncology is Dr. Vanderweele's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Vanderweele is licensed in Illinois.

Specialties and state licenses

  • Medical oncology, IllinoisPrimaryLicense 036123890 · taxonomy 207RX0202X

Medical oncologists near Dr. Vanderweele

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David J. Vanderweele billed Medicare for 47,558 services in 2024

CMS data shows 47,558 Medicare services from Dr. Vanderweele across 38 procedure codes in 2024, for 537 Medicare patients. Medicare paid $1,062,936 for them. Every service was in an office.

Medicare services, 202447,558
Medicare patients537
Paid by Medicare$1.1M
Procedure codes38

Dr. Vanderweele's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 40,3322024: 44,26110%
Other services
2023: 1,5182024: 1,19122%
Tests and treatments
2023: 1,0522024: 1,0974%
Office and hospital visits
2023: 7392024: 99635%
Surgery
2023: 02024: 13

Dr. Vanderweele compared with the Illinois median for medical oncologists, 2024

  • Dr. Vanderweele
  • Illinois median
Medicare services
47,558vs 67170.9 times
Medicare patients
537vs 2302.3 times
Part D claims
789vs 3452.3 times

Medians across 140 medical oncologists in Illinois with Dmand AI profiles that report each measure.

Dr. Vanderweele's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Vanderweele

Need commercial claims for Dr. Vanderweele?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Vanderweele and other medical oncologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. David J. Vanderweele treated 537 Medicare patients in 2024, average age 75

CMS counts 537 Medicare patients who saw Dr. Vanderweele in 2024. The largest group is 65 to 74, with 245 patients. 71% of them have cancer, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 2.49, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vanderweele's median patient age at 74, with 14% women.

Medicare patients, 2024537
Average age75
Average risk score2.49
Also on Medicaid10%

Dr. Vanderweele's Medicare patients by age, 2024

Dr. Vanderweele's Medicare patients by sex, 2024

  • Women12323%
  • Men41477%

Chronic conditions among Dr. Vanderweele's Medicare patients, 2024

  1. Cancer71%
  2. High blood pressure70%
  3. High cholesterol70%
  4. Arthritis39%
  5. Ischemic heart disease32%
  6. Chronic kidney disease28%
  7. Diabetes24%
  8. Anxiety22%

Share of Medicare patients with each condition. A patient can have several.

Dr. Vanderweele's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women14%
  • Men86%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. David J. Vanderweele wrote 947 Medicare Part D claims in 2024

In 2024, Dr. Vanderweele wrote 947 Medicare Part D claims for 166 patients. 62% of them were for generic drugs. CMS names the drug for 789 of them, across 12 drugs with 11 or more claims each, at $3,206,257 in total drug cost. In 2023, CMS named 462 claims across 9 drugs.

Part D claims, 2024947
Drugs named by CMS12
Total drug cost$3.2M
Part D patients166

Dr. Vanderweele's Part D claims by kind of drug, 2024

  • Generic588 claims62%
  • Brand-name359 claims38%

Dr. Vanderweele's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Vanderweele's Part D claims, 2024

  • Opioids1%12 of 947 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4622024: 78971%

Drugs named by CMS: 12 in 2024, 9 in 2023.

See all prescribing by Dr. Vanderweele

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. David J. Vanderweele scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Vanderweele for performance year 2024, reported through an alternative payment model (APM). Dr. Vanderweele accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vanderweele as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Vanderweele's MIPS scores, performance year 2024

  • 95of 100Final score
  • 83of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Vanderweele by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David J. Vanderweele has 11 publications on record

Dmand AI links 11 papers to Dr. Vanderweele, published from 2022 to 2025. 2023 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Castration-Resistant, Antineoplastic Agents and Prostatic Neoplasms. Dr. Vanderweele has published most often in Oncologist. Dr. Vanderweele's most frequent co-authors are Fatima Hafiz Karzai, MD, Ravi Amrit Madan, MD and Ridwan I. Alam, MD, MPH.

Papers11
Years published2022 to 2025

Dr. Vanderweele's papers by year, 2022 to 2025

Topics Dr. Vanderweele writes about most

  • Prostatic Neoplasms, Castration-Resistant
  • Antineoplastic Agents
  • Prostatic Neoplasms

Dr. Vanderweele's most frequent co-authors

Recent publications by Dr. Vanderweele

See all 11 publications and co-authors

See who Dr. Vanderweele researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Vanderweele works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David J. Vanderweele received $31,168 in industry payments from 2016 to 2025

CMS Open Payments shows 55 general payments to Dr. Vanderweele from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $20,572.

General payments to Dr. Vanderweele by program year, 2016 to 2025

General payments to Dr. Vanderweele by kind, 2016 to 2025

$31.2Kin total
  • Consulting fees$22,32072%
  • Speaker and faculty fees$3,96013%
  • Travel and lodging$2,8249%
  • Food and beverage$2,0657%

Companies that paid Dr. Vanderweele the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Vanderweele

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. David J. Vanderweele graduated from University of Chicago, Pritzker School of Medicine

Dr. Vanderweele graduated from University of Chicago, Pritzker School of Medicine in 2007.

  1. Medical schoolUniversity of Chicago, Pritzker School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. David J. Vanderweele's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David J. Vanderweele

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David J. Vanderweele's NPI number?

Dr. David J. Vanderweele's NPI number is 1689846834. It was assigned on March 27, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. David J. Vanderweele?

Dr. David J. Vanderweele is a medical oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. David J. Vanderweele practice?

Dr. Vanderweele practices at 675 N St Clair St, Chicago, IL 60611. Dr. Vanderweele's primary practice is Northwestern Medical Group in Chicago, Illinois. Dmand AI also links Dr. Vanderweele to 4 hospitals, 1 group practice or clinic and 1 hospice.

What is Dr. David J. Vanderweele's office phone number?

The practice phone on file for Dr. Vanderweele is (312) 695-0646.

What is Dr. David J. Vanderweele's medical license number?

Dr. Vanderweele holds Illinois license 036123890.

Which hospitals is Dr. David J. Vanderweele affiliated with?

Dr. Vanderweele is affiliated with Northwestern Memorial Hospital. Dmand AI links Dr. Vanderweele to 4 more hospitals.

What medical group is Dr. David J. Vanderweele part of?

Dr. Vanderweele is linked to Northwestern Medical Faculty Foundation.

Does Dr. David J. Vanderweele accept Medicare?

Yes. CMS data shows Dr. Vanderweele billed Medicare for 47,558 services in 2024, and Dr. Vanderweele accepts Medicare assignment.

Does Dr. David J. Vanderweele offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Vanderweele as offering telehealth services.

What is Dr. David J. Vanderweele's MIPS score?

Dr. Vanderweele's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. David J. Vanderweele see?

CMS counts 537 Medicare patients who saw Dr. Vanderweele in 2024, with an average age of 75.

What services does Dr. David J. Vanderweele bill to Medicare?

In 2024, Dr. Vanderweele's most billed Medicare services were injected or infused drug (J9144), injected or infused drug (J0897) and injected or infused drug (J1453).

Where did Dr. David J. Vanderweele go to medical school?

Dr. Vanderweele graduated from University of Chicago, Pritzker School of Medicine in 2007.

What drugs does Dr. David J. Vanderweele prescribe most?

In 2024 Medicare Part D data, Dr. Vanderweele's most prescribed drugs by claims were Prednisone, Orgovyx and Abiraterone Acetate.

Has Dr. David J. Vanderweele received payments from drug or device companies?

CMS Open Payments shows $31,168 in general payments to Dr. Vanderweele from 7 companies from 2016 to 2025. The largest total came from Bayer HealthCare Pharmaceuticals Inc.

How long has Dr. David J. Vanderweele been practicing?

Dr. Vanderweele graduated from medical school in 2007, 19 years ago.

Does Dr. David J. Vanderweele do research?

Dmand AI links 11 publications to Dr. Vanderweele, published from 2022 to 2025.

Who does Dr. David J. Vanderweele publish with?

Dr. Vanderweele's most frequent co-authors are Fatima Hafiz Karzai, MD (2 shared papers), Ravi Amrit Madan, MD (2 shared papers) and Ridwan I. Alam, MD, MPH (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)